| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |